No single treatment stands out as the most effective for alcohol dependence. The best outcomes come from combining medication with behavioral therapy, and the right combination depends on whether your goal is complete abstinence or reducing how much you drink. A meta-analysis of combined approaches found that using more than one treatment together increased abstinence rates by about 4% over single treatments alone, a modest but meaningful improvement in a condition where every percentage point matters.
Three FDA-Approved Medications
For over 40 years, disulfiram was the only medication available for alcohol dependence. It works by making you physically ill if you drink: nausea, skin flushing, and other unpleasant reactions. The idea is that anticipating those effects keeps you from picking up a drink. The catch is that it only works when you actually take it. Studies going back to the early 1980s have shown that supervised administration is crucial. When someone else watches you take the pill (a spouse, a clinician, a pharmacist), outcomes improve dramatically. One study found a 13-fold reduction in alcohol-related offending with supervised use. Without supervision, many people simply stop taking it or find ways around it.
Naltrexone, approved as a pill in 1994 and as a monthly injection in 2006, works completely differently. It blocks the receptors in your brain responsible for the pleasurable buzz you get from alcohol. Over time, this dulls the reward, reduces cravings, and makes it easier to cut back. Naltrexone is particularly strong at reducing heavy drinking days.
Acamprosate, approved in 2004, targets a different part of the brain. When you quit drinking after a long period of heavy use, your brain becomes hyperexcitable, producing anxiety, restlessness, and discomfort that make relapse tempting. Acamprosate calms that overactivity, easing the physical and emotional turbulence of early sobriety.
Choosing Between Naltrexone and Acamprosate
A major meta-analysis comparing the two medications found that they excel at different things. Acamprosate had a significantly larger effect on maintaining complete abstinence, roughly three times the effect size of naltrexone for that outcome. Naltrexone, on the other hand, was significantly better at reducing heavy drinking days and cravings.
The practical takeaway: if your goal is to stop drinking entirely, acamprosate is the stronger choice. If your goal is to cut back on heavy drinking, naltrexone is more effective. This distinction matters because not everyone enters treatment with the same objective, and matching the medication to your goal improves your chances.
Injectable vs. Oral Naltrexone
One of the biggest challenges with any medication for alcohol dependence is simply taking it consistently. A randomized trial of hospitalized patients compared oral naltrexone (a daily pill) with the extended-release injectable form (a shot given once a month). After three months, only 26.6% of people assigned to the pill had high adherence, compared with 40.7% of those getting the injection. The odds of sticking with treatment were roughly 1.9 times higher with the injectable version.
That gap is significant because medications only work when you take them. If you know daily pill-taking is a struggle, the monthly injection removes that barrier entirely. You show up, get the shot, and you’re covered for the next four weeks.
Behavioral Therapies That Work
Medication addresses the biological side of dependence. Behavioral therapy addresses the patterns, triggers, and emotional underpinnings that keep the cycle going. Three approaches have the strongest evidence.
Cognitive behavioral therapy (CBT) helps you identify the situations and thought patterns that lead to drinking, then builds specific skills to handle them differently. In clinical trials, people who completed a full 12-session course had significantly fewer heavy drinking days and better overall functioning at one year and even three years after treatment, compared to those who attended only one or two sessions. CBT’s effects were the most durable across all time points measured.
Twelve-step facilitation (TSF) is a structured program designed to get you actively involved in Alcoholics Anonymous or similar groups. It produced similar reductions in heavy drinking as CBT through the first year, though its benefits at the three-year mark were somewhat less consistent. Where TSF shines is in building a long-term recovery community. Research on AA involvement shows that meeting attendance, completing steps, having a sponsor, and identifying as a member all independently predict better drinking outcomes. Having a sponsor in particular is associated with longer periods of abstinence and lower psychiatric severity.
Motivational enhancement therapy (MET) takes a different approach. Instead of teaching coping skills or connecting you to a group, it helps you resolve your own ambivalence about changing. It’s brief, typically four sessions, and works well for people who aren’t sure they’re ready for a full treatment program. Those who completed all four sessions had significantly fewer heavy drinking days at both post-treatment and the one-year mark.
Why Combination Treatment Outperforms
The strongest evidence points toward combining medication with therapy rather than relying on either alone. One compelling example: when naltrexone was combined with an antidepressant in people who had both alcohol dependence and depression, the combination produced significantly higher abstinence rates and longer time before relapse than either medication given individually or a placebo. Behavioral therapy was part of the treatment protocol in that study as well.
This makes intuitive sense. Medication reduces the biological pull toward alcohol, cravings, withdrawal discomfort, the rewarding buzz. Therapy gives you the tools to navigate the situations where those cravings hit hardest. Neither alone covers the full picture.
Off-Label Options Gaining Ground
Two medications not officially approved for alcohol dependence have shown clinical promise. Gabapentin, typically used for nerve pain and seizures, reduced alcohol-cued cravings in clinical studies and also improved sleep and mood, two areas where people in early recovery struggle badly. A randomized trial found sustained improvements in drinking outcomes among people who responded well to it. Gabapentin may be especially useful if you’re dealing with anxiety, insomnia, or lingering withdrawal symptoms alongside your drinking.
Topiramate, an anti-seizure medication, has also shown efficacy in reducing heavy drinking, though it comes with more noticeable side effects including cognitive fogginess and tingling in the hands and feet. Neither medication is a first-line choice, but both expand the options when standard treatments haven’t worked or aren’t well tolerated.
How Long Treatment Lasts
Recovery from alcohol dependence isn’t a sprint. Experts generally break it into stages. The abstinence stage, where you’re focused on simply not drinking and building initial stability, lasts one to two years. The repair stage, where you’re rebuilding relationships, work life, and physical health, typically runs two to three years. The growth stage, which starts roughly three to five years in, is about building a life that no longer revolves around alcohol or recovery from it. This stage is expected to continue indefinitely.
These timelines matter for treatment planning. Stopping medication after a few months because you feel better is one of the most common mistakes. The research on behavioral therapy also reinforces this: completing the full course of sessions produced benefits that persisted for years, while dropping out early dramatically reduced long-term gains. Treatment that’s too short for the severity of the problem is a setup for relapse.
Severity Shapes the Approach
Alcohol use disorder is now classified on a spectrum. If you meet two to three of the diagnostic criteria (things like drinking more than intended, unsuccessful attempts to cut back, cravings, tolerance), your condition is considered mild. Four to five criteria is moderate. Six or more is severe. Where you fall on this spectrum should shape your treatment plan.
Mild cases may respond well to brief interventions like motivational enhancement therapy, possibly without medication. Moderate cases typically benefit from a structured therapy program combined with naltrexone or acamprosate. Severe cases often need the full combination: medication, intensive therapy (sometimes residential), and long-term support through groups like AA. The more severe the dependence, the more layers of treatment are generally needed to produce lasting change.